Abstract
Social, economic, and cultural factors can influence the likelihood of exposure to the virus of each person in sanitary emergencies like those of COVID-19. In this sense, parallel to the biological vulnerability to infection with SARS-CoV-2, said factors determine a complementary vulnerability to infection. Hence, they can influence in gender and age distributions of those confirmed, which is not entirely comprehended yet. The effect that age and gender can have on total vulnerability in Mexico thus far is not understood. A better understanding of such dependence can help policy optimization and decision-making to future similar emergencies. We aim to study the age and gender distributions of those confirmed with COVID-19 in Mexico. We also investigate the vulnerability to the infection with SARS-CoV-2 depending on such features. Two different samples of the Mexican population are analyzed in this non-experimental study to compare each other and evaluate the association of the result of the COVID-19 test with gender and age. Data up until the beginning of the vaccination are considered. The percentage of confirmed males is higher than females in both samples, and most tested and confirmed are working-age. Age distributions are positively skewed, with the peak in [30,39] years, which disagrees with the distribution of the Mexican population. The data suggest that the vulnerability to infection weakly depends on gender and age. Males were identified as the most vulnerable gender, and the age group [70,79] showed a higher vulnerability to infection.
Competing Interest Statement
The authors declare the following financial interests/personal relationships that may be considered as potential competing interests. A. Maldonado is the director of the data science division in BMSA Group, the company that financed the study and provided sample 2. M. Reyes participated in the development of this work under his work activities within the data science division of BMSA Group.
Funding Statement
This work was supported by BMSA Group, a Mexican company that did not influence the results at all.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Faculty of Medicine's Research Ethics Committee of the National Autonomous University of Mexico stated that the study is classified as risk-free research and does not require ethical oversight. The letter with the resolution of the ethics committee in English is in process and, upon your request, can be sent when it is available.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data by age and gender supporting the findings of this study are available from http://dx.doi.org/10.17632/6jgry5n75w.1.
